Systematic Reviews
Copyright ©The Author(s) 2015.
World J Gastroenterol. Dec 14, 2015; 21(46): 13177-13187
Published online Dec 14, 2015. doi: 10.3748/wjg.v21.i46.13177
Table 1 Summary of included studies evaluating the treatment of early gastric cancer
Ref.Study designNo. of patientsInclusion criteriaEASAFollow-up (median)Outcomes
EA + SA
Nishida et al[16]RC109AIEMR, laserNot specified(2-3 yr)3-5 yr SR + CRR
Fukase et al[14]RC175AIEMR, HFC, laserNot specified6 mo (5-10 yr)5-10 yr SR + CRR
Kim et al[17]RC55AIEMR-LGastr + lymphadenect35.3 mo + 29.3 mo3 yr SR + CRR + RR
Etoh et al[15]RC93AIEMRGastrectomy57 mo3-5 yr SR + CRR + AER + MR
Choi et al[18]RC551AIEMRGastrectomy81 mo + 88 mo3-5-10 yr SR + RR + AER + MR
Chiu et al[19]RC114AIESDGastr + lymphadenect27 mo + 77.6 mo3 yr SR + AER + MR
Fukunaga et al[20]RC287AI or EIESDNot specified45.3 mo + 67.2 mo5 yr SR + AER + RR
Park et al[21]RC225AI or EIESDGastr + lymphadenect17.6 mo + 24.2 mo5 yr SR + RR + AER + MR
Kim et al[22]RC213AI or EIESDGastr + lymphadenect76.7 mo + 65.5 mo3 yr + 5 yr + CRR + AER + RR
Choi et al[23]RC375AIEMR, ESDGastr + lymphadenect76.4 mo5 yr SR + RR + AER
Kim et al[24]RC457EIEMR, ESDGastr + lymphadenect58.6 mo5 yr SR + RR + AER
Table 2 Quality measures of the analyzed studies: Newcastle-Ottawa Scale - Bias measures
Ref.Representativeness of exposed cohort and selection of the non exposed cohort (max. 2 points)Ascertainment of exposure (max. 1 point)Demonstration that outcome of interest was not present at start of study (max. 1 point)Comparability of cohorts on the basis of the design or analysis (max. 2 points)Assessment of outcome (max. 1 point)Length and adequacy of follow up (max. 2 points)Score and levels of evidence
Nishida et al[16]2111117 - 2b - acceptable (+)
Fukase et al[14]2111117 - 2b - acceptable (+)
Kim et al[17]2112129 - 2b - acceptable (+)
Etoh et al[15]2112129 - 2b - acceptable (+)
Choi et al[18]2112129 - 2b - acceptable (+)
Chiu et al[19]2111128 - 2b - acceptable (+)
Fukunaga et al[20]2111128 - 2b - acceptable (+)
Park et al[21]2112129 - 2b - acceptable (+)
Kim et al[22]2112129 - 2b - acceptable (+)
Choi et al[23]2112129 - 2b - acceptable (+)
Kim et al[24]2112129 - 2b - acceptable (+)